Bladder Tone

Belladonna, Cantharis, Causticum, Cina, Equisetum Hyemale, Ignatia Amara, Physalis Alkekengi, Pulsatilla (pratensis), Sepia, Verbascum Thapsus


Liddell Laboratories, Inc.
Human Otc Drug
NDC 50845-0271
Bladder Tone also known as Belladonna, Cantharis, Causticum, Cina, Equisetum Hyemale, Ignatia Amara, Physalis Alkekengi, Pulsatilla (pratensis), Sepia, Verbascum Thapsus is a human otc drug labeled by 'Liddell Laboratories, Inc.'. National Drug Code (NDC) number for Bladder Tone is 50845-0271. This drug is available in dosage form of Spray. The names of the active, medicinal ingredients in Bladder Tone drug includes Artemisia Cina Pre-flowering Top - 6 [hp_X]/mL Atropa Belladonna - 200 [hp_C]/mL Causticum - 200 [hp_C]/mL Equisetum Hyemale Whole - 3 [hp_X]/mL Lytta Vesicatoria - 200 [hp_C]/mL Physalis Alkekengi Fruit - 6 [hp_X]/mL Pulsatilla Pratensis Whole - 12 [hp_X]/mL Sepia Officinalis Juice - 200 [hp_C]/mL Strychnos Ignatii Seed - 200 [hp_C]/mL Verbascum Thapsus Whole - 6 [hp_X]/mL . The currest status of Bladder Tone drug is Active.

Drug Information:

Drug NDC: 50845-0271
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Bladder Tone
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Belladonna, Cantharis, Causticum, Cina, Equisetum Hyemale, Ignatia Amara, Physalis Alkekengi, Pulsatilla (pratensis), Sepia, Verbascum Thapsus
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Liddell Laboratories, Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Spray
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:ARTEMISIA CINA PRE-FLOWERING TOP - 6 [hp_X]/mL
ATROPA BELLADONNA - 200 [hp_C]/mL
CAUSTICUM - 200 [hp_C]/mL
EQUISETUM HYEMALE WHOLE - 3 [hp_X]/mL
LYTTA VESICATORIA - 200 [hp_C]/mL
PHYSALIS ALKEKENGI FRUIT - 6 [hp_X]/mL
PULSATILLA PRATENSIS WHOLE - 12 [hp_X]/mL
SEPIA OFFICINALIS JUICE - 200 [hp_C]/mL
STRYCHNOS IGNATII SEED - 200 [hp_C]/mL
VERBASCUM THAPSUS WHOLE - 6 [hp_X]/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 28 Sep, 2020
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 23 Dec, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Liddell Laboratories, Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UPC:0363113258967
UPC stands for Universal Product Code.
UNII:28M1820ACT
WQZ3G9PF0H
DD5FO1WKFU
59677RXH25
3Q034RO3BT
2042VC712P
8E272251DI
QDL83WN8C2
1NM3M2487K
C9TD27U172
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
50845-0271-130 mL in 1 BOTTLE, SPRAY (50845-0271-1)28 Sep, 2020N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Indications: may temporarily relieve symptoms associated with abnormal bladder function.** **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

Product Elements:

Bladder tone belladonna, cantharis, causticum, cina, equisetum hyemale, ignatia amara, physalis alkekengi, pulsatilla (pratensis), sepia, verbascum thapsus atropa belladonna atropa belladonna lytta vesicatoria lytta vesicatoria causticum causticum artemisia cina pre-flowering top artemisia cina flower equisetum hyemale whole equisetum hyemale strychnos ignatii seed strychnos ignatii seed physalis alkekengi fruit physalis alkekengi fruit pulsatilla pratensis whole pulsatilla pratensis sepia officinalis juice sepia officinalis juice verbascum thapsus whole verbascum thapsus water alcohol

Indications and Usage:

Indications: may temporarily relieve symptoms associated with abnormal bladder function.** **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

Warnings:

Warnings: if symptoms persist for more than 7 days, consult a doctor. if pregnant or breast feeding, ask a doctor before use. keep out of reach of children. in case of overdose, get medical help or call a poison control center right away. do not use if tamper evident seal around neck of bottle is missing or broken.

Dosage and Administration:

Directions: adults and children over 12: spray twice under the tongue 3 times per day. children 12 and under: consult a doctor prior to use.

Package Label Principal Display Panel:

Package label display: oral sprays liddell laboratories est. 1994 bladder tone homeopathic 1.0 fl. oz. (30 ml) bladder tone

Further Questions:

Questions: dist. by liddell laboratories inc. woodbine, ia 51579 www.liddell.net 1-800-460-7733


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.